VentriPoint Diagnostics logo

VPT - VentriPoint Diagnostics News Story

C$0.17 0.0  3.0%

Last Trade - 22/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £8.69m
Enterprise Value £9.08m
Revenue £21.5k
Position in Universe 1686th / 2682

BRIEF-Ventripoint Receives Market Clearance From U.S. FDA For Complete Heart Analysis System Using 2D Ultrasound

Wed 16th May, 2018 1:43pm
May 16 (Reuters) - VentriPoint Diagnostics Ltd  VPT.V :
    * VENTRIPOINT RECEIVES MARKET CLEARANCE FROM US-FDA FOR
COMPLETE
HEART ANALYSIS SYSTEM USING 2D ULTRASOUND

Source text for Eikon:  ID:nGNX33Xwlm 
Further company coverage:  VPT.V 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.